Pricing of drugs codeveloped by federal laboratories and private companies [microform] : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993.
United States.Congress.House.Committee on Small Business.Subcommittee on Regulation, Business Opportunities, and Technology.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,
1993.
Includes bibliographical references.
"Serial no. 103-2."
Microfiche.
Drugs
Orphan drugs
Drugs
Pharmaceutical industry